Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jacobson

Showing results (361-370 of 792) with videos related to

Pageof 80
Sort By:
Lancet (London, England)|August 26, 1989
Carnitine deficiency induced by pivampicillin and pivmecillinam therapyE Holme, J Greter, C E Jacobson, et al.
Journal of Medicinal Chemistry|February 1, 1989
Selective and enantiospecific acylation of kappa opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexy l] benzeneacetamide. Demonstration of kappa receptor heterogeneityB R de Costa, R B Rothman, V Bykov, et al.
Life Sciences|January 1, 1983
Probes for narcotic receptor mediated phenomena. 5. Narcotic antagonist irreversible ligands based on endoethenotetrahydrooripavineA E Jacobson, B S Bajwa, R A Streaty, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 10, 1982
De novo malignant tumours in renal transplant recipientsM J Cassidy, P B Disler, C R Swanepoel, et al.
Neuropeptides|May 1, 1984
Morphine noncompetitively inhibits [3H]leucine enkephalin binding to membranes lacking type-II delta binding sites: evidence for a two-site allosteric modelR B Rothman, C B Pert, A E Jacobson, et al.
The Journal of Organic Chemistry|May 17, 1974
Synthesis of 2,9beta-dimethyl-6,7-benzomorphanT Oh-Ishi, A E Jacobson, R S Wilson, et al.
JAMA Health Forum|November 22, 2023
Consistency and Adequacy of Public and Commercial Health Insurance for US Children, 2016 to 2021Jamie R Daw, Sarra Yekta, Faelan E Jacobson-Davies, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|March 1, 1996
Optimal photographic imaging of the bulbar conjunctival vasculatureJ R Palmer, C G Owen, A M Ford, et al.
JAMA|July 7, 1978
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatmentG L Knatterud, C R Klimt, M E Levin, et al.
Dermatology (Basel, Switzerland)|August 14, 2023
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescents, and Adult Subjects (Ages 2 Years and Older) with Mild-to-Moderate Atopic DermatitisMichael E Jacobson, Ian A Myles, Amy S Paller, et al.
Pageof 80

Showing results (361-370 of 792) with videos related to

Sort By:
Pageof 80
Lancet (London, England)|August 26, 1989
Carnitine deficiency induced by pivampicillin and pivmecillinam therapyE Holme, J Greter, C E Jacobson, et al.
Journal of Medicinal Chemistry|February 1, 1989
Selective and enantiospecific acylation of kappa opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexy l] benzeneacetamide. Demonstration of kappa receptor heterogeneityB R de Costa, R B Rothman, V Bykov, et al.
Life Sciences|January 1, 1983
Probes for narcotic receptor mediated phenomena. 5. Narcotic antagonist irreversible ligands based on endoethenotetrahydrooripavineA E Jacobson, B S Bajwa, R A Streaty, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 10, 1982
De novo malignant tumours in renal transplant recipientsM J Cassidy, P B Disler, C R Swanepoel, et al.
Neuropeptides|May 1, 1984
Morphine noncompetitively inhibits [3H]leucine enkephalin binding to membranes lacking type-II delta binding sites: evidence for a two-site allosteric modelR B Rothman, C B Pert, A E Jacobson, et al.
The Journal of Organic Chemistry|May 17, 1974
Synthesis of 2,9beta-dimethyl-6,7-benzomorphanT Oh-Ishi, A E Jacobson, R S Wilson, et al.
JAMA Health Forum|November 22, 2023
Consistency and Adequacy of Public and Commercial Health Insurance for US Children, 2016 to 2021Jamie R Daw, Sarra Yekta, Faelan E Jacobson-Davies, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|March 1, 1996
Optimal photographic imaging of the bulbar conjunctival vasculatureJ R Palmer, C G Owen, A M Ford, et al.
JAMA|July 7, 1978
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatmentG L Knatterud, C R Klimt, M E Levin, et al.
Dermatology (Basel, Switzerland)|August 14, 2023
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescents, and Adult Subjects (Ages 2 Years and Older) with Mild-to-Moderate Atopic DermatitisMichael E Jacobson, Ian A Myles, Amy S Paller, et al.
Pageof 80